Study of CTS-1027 in Hepatitis C Patients
Public ClinicalTrials.gov record NCT00570336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose Response Study of CTS-1027 in Hepatitis C Patients
Study identification
- NCT ID
- NCT00570336
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Conatus Pharmaceuticals Inc.
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- CTS-1027 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Jun 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Sep 15, 2010
2007 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Kaiser Permanente | San Diego | California | 92154 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Digestive Healthcare of Georgia | Atlanta | Georgia | 30309 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Henry Ford Health System | West Bloomfield | Michigan | 48322 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Mt. Sinai School of Medicine | New York | New York | 10019 | — |
| Bronx VA Medical Center | The Bronx | New York | 10468 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Consultants of Clinical Research | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Advanced Liver Therapies - Baylor College of Medicine | Houston | Texas | 77030 | — |
| VAMC - Baylor College of Medicine | Houston | Texas | 77030 | — |
| McGuire Hospital DVAMC | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00570336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2010 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00570336 live on ClinicalTrials.gov.